Cargando…

Catheter-free Period Over 2 Days Is Associated with Better Outcome in Catheter-related Bloodstream Infection due to Candida

BACKGROUND: Regardless of active antifungal drugs, mortality of candidemia remains high. Although it is well-known that central venous catheter (CVC) is one of the most important risk factors of candidemia and should be removed immediately, little is known about optimal timing of CVC replacement aft...

Descripción completa

Detalles Bibliográficos
Autores principales: Matsuo, Takahiro, Mori, Nobuyoshi, Hoshino, Eri, Sakurai, Aki, Furukawa, Keiichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5631846/
http://dx.doi.org/10.1093/ofid/ofx162.126
_version_ 1783269573296914432
author Matsuo, Takahiro
Mori, Nobuyoshi
Hoshino, Eri
Sakurai, Aki
Furukawa, Keiichi
author_facet Matsuo, Takahiro
Mori, Nobuyoshi
Hoshino, Eri
Sakurai, Aki
Furukawa, Keiichi
author_sort Matsuo, Takahiro
collection PubMed
description BACKGROUND: Regardless of active antifungal drugs, mortality of candidemia remains high. Although it is well-known that central venous catheter (CVC) is one of the most important risk factors of candidemia and should be removed immediately, little is known about optimal timing of CVC replacement after removal. Here, we analyzed contributing risk factors associated with 30-day mortality for catheter-related bloodstream infection (CRBSI) due to candida and optimal timing of CVC replacement. METHODS: We conducted a retrospective cohort study at St. Luke#129; fs International Hospital between 2004 and 2015. We compared each clinical component in patients who died within 30 days and were alive at 30 days. Also, catheter-free period (from removal to replacement) was compared between group A and B. Fisher#129; fs exact test and Mann–Whitney U test were used in univariate analysis and multivariate linear regression was used for controlling confoundings. RESULTS: Among 228 patients (pts) with candidemia, 166 patients (73%) were on CVC at diagnosis. Of them, 144 patients (65%) removed CVC after the result of candidemia. Seventy-one patients (31%) replaced CVC. Fifteen patients (6%) died within 30 days (group A) and 56 patients (25%) were alive at 30 days (group B). Median age was 74 in group A and 72 in group B (P = 0.331) (Table 1). In univariate analysis, hematological malignancy (OR 6.75, 95% CI 1.01–44.9) and CVC replacement < 2-days after removal (OR 5.63, 95% CI 1.16–27.3) showed statistically significant increase in group A vs group B (Table 2). In multivariate analysis, CVC replacement < 2-days was independently associated with 30-day mortality (Table 3). CONCLUSION: This is the first study to demonstrate the optimal timing of CVC replacement in CRBSI due to candida. CVC replacement < 2 days was an independent risk factor for 30-day mortality. DISCLOSURES: All authors: No reported disclosures.
format Online
Article
Text
id pubmed-5631846
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-56318462017-11-07 Catheter-free Period Over 2 Days Is Associated with Better Outcome in Catheter-related Bloodstream Infection due to Candida Matsuo, Takahiro Mori, Nobuyoshi Hoshino, Eri Sakurai, Aki Furukawa, Keiichi Open Forum Infect Dis Abstracts BACKGROUND: Regardless of active antifungal drugs, mortality of candidemia remains high. Although it is well-known that central venous catheter (CVC) is one of the most important risk factors of candidemia and should be removed immediately, little is known about optimal timing of CVC replacement after removal. Here, we analyzed contributing risk factors associated with 30-day mortality for catheter-related bloodstream infection (CRBSI) due to candida and optimal timing of CVC replacement. METHODS: We conducted a retrospective cohort study at St. Luke#129; fs International Hospital between 2004 and 2015. We compared each clinical component in patients who died within 30 days and were alive at 30 days. Also, catheter-free period (from removal to replacement) was compared between group A and B. Fisher#129; fs exact test and Mann–Whitney U test were used in univariate analysis and multivariate linear regression was used for controlling confoundings. RESULTS: Among 228 patients (pts) with candidemia, 166 patients (73%) were on CVC at diagnosis. Of them, 144 patients (65%) removed CVC after the result of candidemia. Seventy-one patients (31%) replaced CVC. Fifteen patients (6%) died within 30 days (group A) and 56 patients (25%) were alive at 30 days (group B). Median age was 74 in group A and 72 in group B (P = 0.331) (Table 1). In univariate analysis, hematological malignancy (OR 6.75, 95% CI 1.01–44.9) and CVC replacement < 2-days after removal (OR 5.63, 95% CI 1.16–27.3) showed statistically significant increase in group A vs group B (Table 2). In multivariate analysis, CVC replacement < 2-days was independently associated with 30-day mortality (Table 3). CONCLUSION: This is the first study to demonstrate the optimal timing of CVC replacement in CRBSI due to candida. CVC replacement < 2 days was an independent risk factor for 30-day mortality. DISCLOSURES: All authors: No reported disclosures. Oxford University Press 2017-10-04 /pmc/articles/PMC5631846/ http://dx.doi.org/10.1093/ofid/ofx162.126 Text en © The Author 2017. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Abstracts
Matsuo, Takahiro
Mori, Nobuyoshi
Hoshino, Eri
Sakurai, Aki
Furukawa, Keiichi
Catheter-free Period Over 2 Days Is Associated with Better Outcome in Catheter-related Bloodstream Infection due to Candida
title Catheter-free Period Over 2 Days Is Associated with Better Outcome in Catheter-related Bloodstream Infection due to Candida
title_full Catheter-free Period Over 2 Days Is Associated with Better Outcome in Catheter-related Bloodstream Infection due to Candida
title_fullStr Catheter-free Period Over 2 Days Is Associated with Better Outcome in Catheter-related Bloodstream Infection due to Candida
title_full_unstemmed Catheter-free Period Over 2 Days Is Associated with Better Outcome in Catheter-related Bloodstream Infection due to Candida
title_short Catheter-free Period Over 2 Days Is Associated with Better Outcome in Catheter-related Bloodstream Infection due to Candida
title_sort catheter-free period over 2 days is associated with better outcome in catheter-related bloodstream infection due to candida
topic Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5631846/
http://dx.doi.org/10.1093/ofid/ofx162.126
work_keys_str_mv AT matsuotakahiro catheterfreeperiodover2daysisassociatedwithbetteroutcomeincatheterrelatedbloodstreaminfectionduetocandida
AT morinobuyoshi catheterfreeperiodover2daysisassociatedwithbetteroutcomeincatheterrelatedbloodstreaminfectionduetocandida
AT hoshinoeri catheterfreeperiodover2daysisassociatedwithbetteroutcomeincatheterrelatedbloodstreaminfectionduetocandida
AT sakuraiaki catheterfreeperiodover2daysisassociatedwithbetteroutcomeincatheterrelatedbloodstreaminfectionduetocandida
AT furukawakeiichi catheterfreeperiodover2daysisassociatedwithbetteroutcomeincatheterrelatedbloodstreaminfectionduetocandida